The regulation of artificial intelligence (AI) has become a hot topic in recent years, especially as AI systems like ChatGPT continue to grow in prominence. OpenAI’s CEO, Sam Altman, recently testified before the Senate Judiciary Committee, emphasizing the need for collaboration…
Source: www.kevinmd.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
